| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |